376 related articles for article (PubMed ID: 7710931)
1. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
2. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
4. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
5. Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues.
Jones T; Courage C; Hubbard A; Gescher A
Biochem Pharmacol; 1997 May; 53(10):1413-8. PubMed ID: 9260867
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells.
Courage C; Snowden R; Gescher A
Br J Cancer; 1996 Oct; 74(8):1199-205. PubMed ID: 8883405
[TBL] [Abstract][Full Text] [Related]
7. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1992 Apr; 51(1):144-8. PubMed ID: 1563835
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors.
Budworth J; Gescher A
FEBS Lett; 1995 Apr; 362(2):139-42. PubMed ID: 7536688
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
Seynaeve CM; Kazanietz MG; Blumberg PM; Sausville EA; Worland PJ
Mol Pharmacol; 1994 Jun; 45(6):1207-14. PubMed ID: 8022414
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA
Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced accumulation of erythropoietin mRNA in isolated hepatocytes is inhibited by protein kinase C.
Eckardt KU; Ring A; Maier M; Gess B; Fabbro D; Kurtz A
Pflugers Arch; 1994 Jan; 426(1-2):21-30. PubMed ID: 8146021
[TBL] [Abstract][Full Text] [Related]
13. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
Harkin ST; Cohen GM; Gescher A
Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
[TBL] [Abstract][Full Text] [Related]
14. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.
Meyer T; Regenass U; Fabbro D; Alteri E; Rösel J; Müller M; Caravatti G; Matter A
Int J Cancer; 1989 May; 43(5):851-6. PubMed ID: 2714889
[TBL] [Abstract][Full Text] [Related]
15. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
Toullec D; Pianetti P; Coste H; Bellevergue P; Grand-Perret T; Ajakane M; Baudet V; Boissin P; Boursier E; Loriolle F
J Biol Chem; 1991 Aug; 266(24):15771-81. PubMed ID: 1874734
[TBL] [Abstract][Full Text] [Related]
16. TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes.
O'Connell MA; Kelleher D; Liskamp RM; Hall N; O'Neill LA; Long A
Cytokine; 1997 Feb; 9(2):83-92. PubMed ID: 9071558
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new protein kinase C inhibitor CGP 41251 on T cell functions: inhibition of activation, growth, and target cell killing.
Alkan SS; Rutschmann S; Grogg D; Erb P
Cell Immunol; 1993 Aug; 150(1):137-48. PubMed ID: 8102085
[TBL] [Abstract][Full Text] [Related]
18. Staurosporine analogues - pharmacological toys or useful antitumour agents?
Gescher A
Crit Rev Oncol Hematol; 2000 May; 34(2):127-35. PubMed ID: 10799837
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic and cytotoxic properties of the marine product bistratene A and analysis of the role of protein kinase C in its mode of action.
Stanwell C; Gescher A; Watters D
Biochem Pharmacol; 1993 May; 45(9):1753-61. PubMed ID: 8494533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
